Gilead Strikes $2.48 Billion Deal with Nurix to Focus on Protein Degradation Jun 19, 2019 Life Science
BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor Jun 18, 2019 Life Science
CASI Acquires Global Rights To CD19 T-Cell Therapy; Will Make $11.6 Million Investment Jun 18, 2019 Life Science
Hansoh Completes $1 Billion Hong Kong IPO; Rises 37% in First Trading Session Jun 14, 2019 Life Science
MORE Health Announces Strategic Collaboration with Memorial Sloan Kettering Cancer Center Jun 13, 2019 Life Science